Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial.

Amira S A Said,Raghda R S Hussein,Doaa Mahmoud Khalil,Alzhraa M Fahmy, Ahmed H A Hassanein,Lamiaa N Abdelaty

Pharmacy practice（2023）

引用 0|浏览2

暂无评分

摘要

These findings suggest that Enoxaparin was safe, effective, and well tolerated and has a role in decreasing the progression of the disease and its complications while HCQ did not discover any evidence of extra therapeutic benefits.

查看译文

关键词

COVID-19 infection,ICU stay,enoxaparin,hydroxychloroquine,length of hospital stay,mortality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要